138 related articles for article (PubMed ID: 36911926)
1. Oligometastatic breast cancer to parotid gland with complete response.
Peron V; Miyasaki Piovesana M; Martins Medeiros E; André Di Ricco B; Teixeira Liutti V
Breast Dis; 2023; 42(1):67-71. PubMed ID: 36911926
[TBL] [Abstract][Full Text] [Related]
2. Parotid gland metastasis from carcinoma of the breast detected by PET/CT: Case report and review.
Cao XS; Cong BB; Yu ZY
Medicine (Baltimore); 2018 May; 97(21):e10616. PubMed ID: 29794736
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of efficacy and safety of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience.
Tiwari A; Gogia A; Deo S; Shukla NK; Mathur S; Sharma DN
Indian J Cancer; 2017; 54(1):343-346. PubMed ID: 29199719
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
Aogi K; Saeki T; Nakamura S; Kashiwaba M; Sato N; Masuda N; Rai Y; Ohno S; Kuroi K; Nishimura R; Miyakoda K; Akiyama F; Kurosumi M; Ikeda T
Int J Clin Oncol; 2013 Aug; 18(4):598-606. PubMed ID: 22833344
[TBL] [Abstract][Full Text] [Related]
5. Rosai-Dorfman disease of the breast and parotid gland.
Dahlgren M; Smetherman DH; Wang J; Corsetti RL
J La State Med Soc; 2008; 160(1):35-8. PubMed ID: 18669407
[TBL] [Abstract][Full Text] [Related]
6. [A case of effective trastuzumab plus gemcitabine therapy for human epidermal growth factor receptor 2-positive breast cancer].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Jinno H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2396-8. PubMed ID: 24394124
[TBL] [Abstract][Full Text] [Related]
7. [A Case of HER2 Positive Occult Breast Cancer Presenting as Swollen Axillary Lymph Nodes].
Ishiba T; Oda G; Nakagawa T; Akashi T; Yamashita Y; Aburatani T; Ogo T; Nakashima Y; Baba H; Hoshino N; Nishioka Y; Kawano T
Gan To Kagaku Ryoho; 2018 Mar; 45(3):533-535. PubMed ID: 29650929
[TBL] [Abstract][Full Text] [Related]
8. Radiation Therapy for Breast Cancer With Oligometastatic Cervical Lymph Nodes: A Case Report.
Burioka H; Yamamori U; Nagano N; Ue A; Tamaki Y
Cureus; 2024 Jan; 16(1):e51617. PubMed ID: 38313990
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Metastasis to the Parotid: A Case Report with Imaging Findings.
Jung HK; Lim YJ; Kim W
Am J Case Rep; 2021 Nov; 22():e934311. PubMed ID: 34813583
[TBL] [Abstract][Full Text] [Related]
10. Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Coudert B; Pierga JY; Mouret-Reynier MA; Kerrou K; Ferrero JM; Petit T; Kerbrat P; Dupré PF; Bachelot T; Gabelle P; Giard S; Coeffic D; Bougnoux P; Prevost JB; Paintaud G; Thibault G; Hernandez J; Coudert M; Arnould L; Berriolo-Riedinger A
Lancet Oncol; 2014 Dec; 15(13):1493-1502. PubMed ID: 25456368
[TBL] [Abstract][Full Text] [Related]
11. The successful application of pyrotinib in the treatment of primary trastuzumab-resistant HER-2-positive breast cancer with bilateral axillary lymph node metastasis: a case report.
Yuan Y; Hu S; Qian Y; Zhang L
Ann Palliat Med; 2021 Jun; 10(6):7138-7145. PubMed ID: 34237992
[TBL] [Abstract][Full Text] [Related]
12. Metastatic involvement of parotid from carcinoma of the breast--a case report.
Dangore-Khasbage SB; Degwekar SS; Bhowate RR; Bhake A
Oral Maxillofac Surg; 2009 Mar; 13(1):49-53. PubMed ID: 19190940
[TBL] [Abstract][Full Text] [Related]
13. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
[TBL] [Abstract][Full Text] [Related]
14. A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.
Shigematsu H; Nakamura Y; Tanaka K; Shiotani S; Koga C; Kawaguchi H; Nishimura S; Taguchi K; Nishiyama K; Ohno S
Int J Clin Oncol; 2010 Dec; 15(6):615-20. PubMed ID: 20473628
[TBL] [Abstract][Full Text] [Related]
15. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
16. [Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity].
Ben Dhia S; Loap P; Loirat D; Vincent-Salomon A; Cao K; Escalup L; Fourquet A; Kirova Y
Cancer Radiother; 2021 Jul; 25(5):424-431. PubMed ID: 33771453
[TBL] [Abstract][Full Text] [Related]
17. [Primary salivary gland tumors in lymph nodes of the parotid gland. Report of 3 cases and review of the literature].
Seifert G
Pathologe; 1997 Mar; 18(2):141-6. PubMed ID: 9244872
[TBL] [Abstract][Full Text] [Related]
18. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
[TBL] [Abstract][Full Text] [Related]
19. A Locally Advanced Breast Cancer that Achieved pCR with Pertuzumab, Trastuzumab and Docetaxel: Case Report.
Inoue Y; Yamashita N; Tokunaga E; Tanaka K; Ueo H; Saeki H; Oki E; Yamamoto H; Maehara Y
Anticancer Res; 2017 Apr; 37(4):1917-1921. PubMed ID: 28373460
[TBL] [Abstract][Full Text] [Related]
20. Kimura disease involving parotid gland and cervical nodes: CT and MR findings.
Som PM; Biller HF
J Comput Assist Tomogr; 1992; 16(2):320-2. PubMed ID: 1545036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
